Bio-Matrix Scientific Group, Inc. (OTCBB:BMSN), a San Diego-based biotechnology company, announced today the launch of a national marketing program aimed at hospitals in need of storing umbilical cord blood specimens for future transplantation. The firm's state-of-the-art 15,000 square foot cryogenic banking and processing facility serves a niche in the "storage" of adult stem cells from umbilical cord blood of patient donors' specimens.